18. 脊髄小脳変性症（多系統萎縮症を除く。） Spinocerebellar degeneration Clinical trials / Disease details

臨床試験数 : 76 / 薬物数 : 98 - (DrugBank : 31) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 65

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04921930 (ClinicalTrials.gov)	July 1, 2021	31/5/2021	Evaluation of the Effect of Artesunate in Friedreich Ataxia (FA)	Evaluation of the Effect of Artesunate in Friedreich Ataxia (FA) Phase I-II Efficacy-Toxicity of Art ...	Friedreich Ataxia	Drug: Artesunate Oral Product	Institut National de la Santé Et de la Recherche Médicale, France	Imagine Institute	Not yet recruiting	16 Years	65 Years	Male	20	Phase 1/Phase 2	NULL

First Previous1Next Last